New research has found that marijuana vaping among teens has doubled from 2013 to 2020, suggesting that policymakers should better regulate cannabis vaping products and ban ads that target teenagers. Regular vaping of marijuana in teenagers could increase the risk of mental health issues.
New research has found that cognitive impairment, or brain fog, could persist for months in hospitalized COVID-19 patients, as well as outpatients. The study found that nearly a quarter of COVID patients reported symptoms of cognitive impairment and memory loss.
New research, published in JAMA Internal Medicine, has found that approved generic drugs for insulin and antiviral agents for treating hepatitis C may lower drug prices for patients but they are unlikely to provide savings to Medicare D Part beneficiaries.
A new study has suggested that using e-cigarettes – even daily – did not help smokers stay off cigarettes. The study, published on the JAMA Network Open, investigated more than 13,600 smokers and found that that switching to e-cigarettes did not help smokers to quit conventional cigarettes.
Dr. Ofer Levy, a voting member of the FDA’s advisory panel, said that top scientists have raised concerns over the risk of mRNA-based COVID boosters causing inflammatory heart conditions. Considering this risk, the scientists are dicey about approving boosters in young adults.
California is on a separate way to reduce prescription drug prices. The state’s legislation, which went into effect January 1, allows California to make its own insulin and other prescription drugs. The legislation aims to lower drug prices and increase patient access to affordable drugs.